Table of Content
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of the Joints and Bones Disorders around the World and Increasing Geriatric Population
4.2.2 Technological Advancements in Cartilage Repair/Regeneration
4.2.3 Increasing Number of Injuries and Accidents
4.3 Market Restraints
4.3.1 High Costs of Cartilage Repair Procedures
4.3.2 Regulatory and Reimbursement Issues
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Types of Cartilage
5.1.1 Fibrocartilage
5.1.2 Hyaline Cartilage
5.1.3 Others
5.2 By Treatment Modality
5.2.1 Cell-based
5.2.2 Non-Cell-based
5.3 By Treatment Type
5.3.1 Palliative
5.3.2 Intrinsic Repair Stimulus
5.4 By Application Site
5.4.1 Knee
5.4.2 Spine
5.4.3 Ankle
5.4.4 Hip
5.4.5 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Anika Therapeutics, Inc.
6.1.2 Arthrex, Inc.
6.1.3 B. Braun Melsungen AG
6.1.4 Cyfuse Biomedical K.K.
6.1.5 DePuy Synthes
6.1.6 Geistlich Pharma AG
6.1.7 Smith & Nephew plc
6.1.8 Stryker Corporation
6.1.9 Vericel Corporation
6.1.10 Zimmer Biomet
7 MARKET OPPORTUNITIES AND FUTURE TRENDS